SYTAW yields 44444.44% · PFE yields 6.13%● Live data
📍 SYTAW pulled ahead of the other in Year 1
Combined, SYTAW + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of SYTAW + PFE for your $10,000?
Siyata Mobile Inc. develops and provides cellular-based communications platform. It develops, markets, and sells rugged handheld Push-to-Talk over Cellular smartphone devices for first responders, construction workers, security guards, government agencies, utilities, transportation and waste management, amusement parks, and mobile workers in various industries. The company also offers VK7 Vehicle Kit and Uniden UV350 4G/LTE, an in-vehicle communication devices that incorporates voice, PoC, data, fleet management solutions, and other Android based applications for professional vehicles, such as trucks, vans, buses, emergency service vehicles, and other enterprise vehicles. In addition, it provides cellular amplifiers to boost the cellular signal inside homes, buildings, and vehicles. The company offers its products under the Uniden Cellular and Siyata brand names. It serves cellular network operators and their dealers, as well as commercial vehicle technology distributors for fleets in the United States, Canada, Europe, Australia, the Middle East, and internationally. The company is headquartered in Montreal, Canada.
Full SYTAW Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.